Lipid Pentad Index: A novel bioindex for evaluation of lipid risk factors for atherosclerosis in young adolescents and children of premature coronary artery disease patients in India

Clinical Biochemistry

Volumn 40, Issue 1-2, 2007, Pages 18-24

  Das, Barnali ^a   Daga, Mradul K ^a   Gupta, Santosh K ^a  

^a LOK NAYAK HOSPITAL   (India)

Author keywords

Adolescents; Apolipoproteins; Atherogenic Index; Children; Lipid Pentad Index; Lipid Tetrad Index; Lipoprotein(a); Premature CAD

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; ATHEROSCLEROSIS; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROBABILITY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEIN B-100; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; CHILD; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; INDIA; LIPOPROTEIN(A); LIPOPROTEINS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 33845755914     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.08.016     Document Type: Article

References (26)

1. Gupta R., and Gupta V.P. Meta-analysis of coronary heart disease prevalence in India. Indian Heart J. 48 (1996) 241-245
2. Enas E.A., and Mehta J. Malignant coronary artery disease in young Asian Indians: thoughts on pathogenesis, prevention and therapy. Coronary Artery Disease in Asian Indians (CADI) Study. Clin. Cardiol. 18 (1995) 131-135
3. Enas E.A., Dhawan J., and Petkar S. Coronary artery disease in Asian Indians: lessons learnt and the role of lipoprotein (a). Indian Heart J. 49 (1997) 25-34
4. Brindle P., Emberson J., Lampe F., et al. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. Br. Med. J. 327 (2003) 1267-1272
5. Isser H.S., Puri V.K., Narain V.S., Saran R.K., Dwivedi S.K., and Singh S. Lipoprotein(a) and lipid levels in young patients with myocardial infarction and their first degree relatives. Indian Heart J. 53 (2001) 463-466
6. Widhalm K., Koch S., Pakosta R., Schurz M., and Brendinger M. Serum lipids lipoproteins and apolipoproteins in children with and without familial history of premature coronary heart disease. J. Am. Coll. Nutr. 11 (1992) 32S-35S [Suppl.]
7. Mohan V., Deepa R., Rani S.S., and Premalatha G. Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: the Chennai urban population study (CUPS No. 5). J. Am. Coll. Cardiol. 38 (2001) 682-687
8. Rifai N., Heiss G., and Doetsch K. Lp(a) at birth in blacks and whites. Atherosclerosis 92 (1992) 123-129
9. Enas E.A., and Jacob S. Coronary artery disease in Indians in USA. In: Sethi K.K. (Ed). Coronary Artery Disease in Indians-A Global Perspective (1998), Mumbai Cardiological Society of India 32-43
10. Enas E.A. Coronary artery disease epidemic in Indians: a cause for alarm and call for action. J. Indian Med. Assoc. 98 (2000) 694-702
11. Mohan V., Deepa R., Haranath S.P., et al. Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India. Diabetes Care 21 (1998) 1819-1823
12. Gupta R., Vasisht S., Bahl V.K., and Wasir H.S. Correlation of lipoprotein(a) to angiographically defined coronary artery disease in Indians. Int. J. Cardiol. 57 (1996) 265-270
13. Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
14. Genest J., McNamara J.R., and Ordovas M.J.M. Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein(a) abnormalities in men with premature coronary artery disease. J. Am. Coll. Cardiol. 19 (1992) 792-802
15. Graziani M.S., Zanolla L., Righetti G., Marchetti C., Mocarelli P., and Marcovina S.M. Plasma apolipoproteins A-I and B in survivors of myocardial infarction and in a control group. Clin. Chem. 44 (1998) 134-140
16. Sniderman A.D., Pedersen T., and Kjekshus J. Putting low-density lipoproteins at center stage in atherogenesis. Am. J. Cardiol. 79 (1997) 64-67
17. Kelishadi R., Zadegan N.S., Nadery G.A., Asgary S., and Bashardoust N. Atherosclerosis risk factors in children and adolescents with or without family history of premature coronary artery disease. Med. Sci. Monit. 8 (2002) CR425-CR429
18. Dobiášová M., and Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FERHDL). Clin. Biochem. 34 (2001) 583-588
19. Tan M.H., Johns D., and Glazer N.B. Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes. Clin. Chem. 50 (2004) 1184-1188
20. Farmer J.A., and Gotto A.M. Dyslipidemia and other risk factors for coronary artery disease. In: Braunwald E. (Ed). Heart disease: a text book of cardiovascular medicine. 5th ed. (1997), W.B. Saunders Co 1126-1160
21. Press W.H., Flannery B.P., Teukolsky S.A., and Vetterling W.T. Numerical recipes in fortran. 2nd ed. (1992), University Press, Cambridge 617-618
22. Singh M. Pediatric clinical methods. 2nd ed. (2003), Sagar Publications, New Delhi 301-325
23. Tietz N.W. Clinical guide to laboratory tests. 3rd ed. (1995), WB Saunders Co, Philadelphia
24. Jenner J.L., Ordovas J.M., Lamon-Fava S., et al. Effect of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Stud. Circulation 87 (1993) 1135-1141
25. Utermann G. The mysteries of lipoprotein(a). Science 246 (1989) 904-910
26. Gosta H.D. Lp(a) lipoprotein in cardiovascular disease. Atherosclerosis 108 (1994) 111-126